Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells
Jee‐Yeong Jeong(Beth Israel Deaconess Medical Center), Arthur J. Sytkowski(IQVIA (United States))
Cited by 59
Related Papers
Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel‐resistant phenotype
|International Journal of Cancer|2007|37
Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells
|Molecular Cancer Therapeutics|2008|22
Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
|Bioorganic & Medicinal Chemistry Letters|2018|14
Location and the functionality of erythropoietin receptor(s) in A2780 cells
|Oncology Reports|2012|11